Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001718815 | SCV000512510 | likely benign | not provided | 2021-03-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000538548 | SCV000637848 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2024-12-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000571904 | SCV000666284 | likely benign | Hereditary cancer-predisposing syndrome | 2015-10-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000571904 | SCV000684480 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-12 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003492036 | SCV004240435 | likely benign | Breast and/or ovarian cancer | 2023-06-12 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001718815 | SCV005219060 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Myriad Genetics, |
RCV000538548 | SCV005406208 | benign | Hereditary diffuse gastric adenocarcinoma | 2024-09-13 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |